Evidence map›Paper›PMID 22328926›Full record

ArticlePloS one2012

Humanin, a cytoprotective peptide, is expressed in carotid atherosclerotic [corrected] plaques in humans.

David G Zacharias, Sung Gyun Kim, Alfonso Eirin Massat, Adi R Bachar, Yun K Oh, Joerg Herrmann, Martin Rodriguez-Porcel, Pinchas Cohen, Lilach O Lerman, Amir Lerman

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Expression Profile of MouseJournal of lifestyle medicine · 2021
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Mitonuclear genomics and aging.Human genetics · 2020
    Review
  15. MOTS-c: A Mitochondrial-Encoded Regulator of the Nucleus.BioEssays : news and reviews in molecular, cellular and developmental biology · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

David G ZachariasDivision of Cardiovascular Diseases, Department of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America.
Sung Gyun Kim
Alfonso Eirin Massat
Adi R Bachar
Yun K Oh
Joerg Herrmann
Martin Rodriguez-Porcel
Pinchas Cohen
Lilach O Lerman
Amir Lerman
Mayo Clinic · USMattel Children's Hospital · US

Funding

Novel Mitochondrially Encoded Peptides and Their Role in Health and DiseaseR01GM090311 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI COHEN, PINCHAS · 2009 to 2013
$3.2M
Mayo Clinic Center for Translational Science ActivitiesTL1RR024152 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 2006 to 2011
$2.5M
Lp-PLA2 and Coronary Atherosclerosis in HumansR01HL092954 · NHLBI · MAYO CLINIC ROCHESTER · PI LERMAN, AMIR · 2009 to 2013
$2.1M
Role of Endothelial Progenitor Cells in vascular Aging and CalcificationR01AG031750 · NIA · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP, LERMAN, AMIR · 2010 to 2014
$2.0M
Plasma Mitochondrial Peptide Assays as Biomarkers of Environmental Toxin ExposureR01ES020812 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI COHEN, PINCHAS · 2011 to 2015
$1.8M
A family of novel mitochondrially-encoded peptides and their role in agingR01AG034430 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI COHEN, PINCHAS · 2009 to 2012
$1.2M
Role of Oxidative Stress in Stem Cell Differentiation and SurvivalR00HL088048 · NHLBI · MAYO CLINIC ROCHESTER · PI RODRIGUEZ-PORCEL, MARTIN · 2009 to 2011
$747k
NCRR NIH HHS 1 TL1 RR024152NCRR NIH HHS TL1 RR024152NHLBI NIH HHS HL92954NHLBI NIH HHS R00 HL088048NHLBI NIH HHS R00 HL88048NHLBI NIH HHS R01 HL092954NIA NIH HHS AG034430NIA NIH HHS AG31750NIA NIH HHS R01 AG031750NIA NIH HHS R01 AG034430NIEHS NIH HHS R01 ES020812NIGMS NIH HHS GM090311NIGMS NIH HHS R01 GM090311
6 · The paper itself

Abstract

objectiveThe mechanism of atherosclerotic plaque progression leading to instability, rupture, and ischemic manifestation involves oxidative stress and apoptosis. Humanin (HN) is a newly emerging endogenously expressed cytoprotective peptide. Our goal was to determine the presence and localization of HN in carotid atherosclerotic plaques. METHODS AND

resultsPlaque specimens from 34 patients undergoing carotid endarterectomy were classified according to symptomatic history. Immunostaining combined with digital microscopy revealed greater expression of HN in the unstable plaques of symptomatic compared to asymptomatic patients (29.42±2.05 vs. 14.14±2.13% of plaque area, p<0.0001). These data were further confirmed by immunoblot (density of HN/β-actin standard symptomatic vs. asymptomatic 1.32±0.14 vs. 0.79±0.11, p<0.01). TUNEL staining revealed a higher proportion of apoptotic nuclei in the plaques of symptomatic patients compared to asymptomatic (68.25±3.61 vs. 33.46±4.46% of nuclei, p<0.01). Double immunofluorescence labeling revealed co-localization of HN with macrophages (both M1 and M2 polarization), smooth muscle cells, fibroblasts, and dendritic cells as well as with inflammatory markers MMP2 and MMP9.

conclusionsThe study demonstrates a higher expression of HN in unstable carotid plaques that is localized to multiple cell types within the plaque. These data support the involvement of HN in atherosclerosis, possibly as an endogenous response to the inflammatory and apoptotic processes within the atheromatous plaque.

Indexed as

ActininAgedApoptosisArginaseBlotting, WesternCarotid Artery DiseasesCarrier ProteinsFemaleHumansIn Situ Nick-End LabelingIntracellular Signaling Peptides and ProteinsMaleMatrix Metalloproteinase 2Matrix Metalloproteinase 9Microfilament ProteinsNitric Oxide Synthase Type IIActininArginaseCarrier ProteinsfascinhumaninIntracellular Signaling Peptides and ProteinsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Microfilament ProteinsNitric Oxide Synthase Type IIVimentin

Identifiers

PMID22328926
PMCPMC3273477
OpenAlexW1993712988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.